Effectiveness of Sacubitril/Valsartan in real-life practice: experience of a single center

被引：0
|
作者：
Joana Neiva, J. N. [1 ]
Gomez-Otero, I. G. O. [2 ]
Varela-Roman, A. V. R. [2 ]
Moure Gonzalez, M. M. G. [2 ]
Seoane Blanco, A. S. B. [2 ]
Gonzalez-Juanatey, J. R. G. J. [2 ]
机构：
[1] Hosp Vila Franca Xira, Vila Franca De Xira, Portugal
[2] Univ Hosp Santiago de Compostela, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Santiago De Compostela, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2177
引用
收藏
页码：582 / 582
页数：1
相关论文
共 50 条
  • [21] The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting
    Mule, Giuseppe
    Sorce, Alessandra
    Nardi, Emilio
    Geraci, Giulio
    Cottone, Santina
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (08) : 1205 - 1208
  • [22] Clinical practice with sacubitril/valsartan: more on the Italian experience
    Ungar, Andrea
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 : 1 - 2
  • [23] Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension
    Irina E. Chazova
    Neelesh Dongre
    Alexey V. Vigdorchik
    Advances in Therapy, 2011, 28 : 134 - 149
  • [24] Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension
    Chazova, Irina E.
    Dongre, Neelesh
    Vigdorchik, Alexey V.
    ADVANCES IN THERAPY, 2011, 28 (02) : 134 - 149
  • [25] Real world experience with sacubitril/valsartan in heart failure
    Lim, E. L. S.
    Abdullah, E. L.
    Loh, L. C. W.
    Chong, P. F.
    Sia, H. P.
    Sothivadivel, S.
    Lee, J. L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
  • [26] SACUBITRIL/VALSARTAN: REAL WORLD EXPERIENCE OF DELIVERY AND TOLERABILITY
    Crawley, Richard
    Guha, Kaushik
    Kalra, Paul
    Morton, Geraint
    HEART, 2017, 103 : A1 - A2
  • [27] Results of a single center experience on 200 consecutive patients treated with Entresto (sacubitril/valsartan).
    Canu, A.
    Maurin, V.
    Dos Santos, P.
    Picard, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 413 - 414
  • [28] Real-Life Clinical Practice with Sorafenib in Advance Hepatocellular Carcinoma: A Single-Center Experience Second Analysis
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Iwanishi, Mina
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Ida, Hiroshi
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kitano, Masayuki
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2015, 33 (06) : 728 - 734
  • [29] Evaluation of tocilizumab-induced hypofibrinogenemia in rheumatology practice: a retrospective, real-life, single-center experience
    Yildirim, Resit
    Cansu, Dondu Uskudar
    Dinler, Mustafa
    Korkmaz, Cengiz
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (12) : 2927 - 2934
  • [30] Experience using sacubitril/valsartan in real life: tolerability and clinical evolution in a long term
    Rafael Bravo Marques, R.
    Timonet Andreu, E.
    Rodriguez Martinez, J. L.
    Lopez Tejero, S.
    Chinchurreta Capote, P. A.
    Corona Barrio, C.
    Siles Rubio, J. R.
    Valle Alberca, A.
    Mesa Prado, F. E.
    Martin Dominguez, C.
    Ruiz Mateas, F.
    Torres Calvo, F. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 222 - 223
12345